ERBB2 and breast cancer: Notably, in this study, the breast cancer biologic subtype constructed according to the status of hormonal receptors and HER2 was demonstrated to be significant for any clinical outcome following salvage treatment for ILRR after mastectomy in both univariate and multivariate models.